|
TERF2IP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26989530002675E-11 |
| Normal-vs-Stage2 |
8.93379999977739E-08 |
| Normal-vs-Stage3 |
1.65178981603731E-12 |
| Normal-vs-Stage4 |
6.28275209635376E-12 |
| Stage1-vs-Stage2 |
2.631200E-01 |
| Stage1-vs-Stage3 |
3.011600E-04 |
| Stage1-vs-Stage4 |
2.612000E-02 |
| Stage2-vs-Stage3 |
2.930400E-01 |
| Stage2-vs-Stage4 |
5.698000E-01 |
| Stage3-vs-Stage4 |
5.162000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6242562850266E-12 |
| Normal-vs-AfricanAmerican |
6.591300E-04 |
| Normal-vs-Asian |
1.234370E-01 |
| Caucasian-vs-AfricanAmerican |
7.578600E-04 |
| Caucasian-vs-Asian |
4.483400E-01 |
| AfricanAmerican-vs-Asian |
9.984200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.81910042584832E-11 |
| Male-vs-Female |
2.405900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.026300E-04 |
| Normal-vs-Age(41-60Yrs) |
3.33469918345486E-11 |
| Normal-vs-Age(61-80Yrs) |
3.1863400806742E-13 |
| Normal-vs-Age(81-100Yrs) |
1.1101000008118E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.805000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.342200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.125700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.741700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.136800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.003800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.767800E-01 |
| Normal-vs-Grade 2 |
5.86564130600209E-12 |
| Normal-vs-Grade 3 |
1.62458935193399E-12 |
| Normal-vs-Grade 4 |
1.32189814650019E-11 |
| Grade 1-vs-Grade 2 |
4.194100E-02 |
| Grade 1-vs-Grade 3 |
2.902000E-03 |
| Grade 1-vs-Grade 4 |
3.140800E-03 |
| Grade 2-vs-Grade 3 |
1.388360E-02 |
| Grade 2-vs-Grade 4 |
8.320400E-02 |
| Grade 3-vs-Grade 4 |
9.492600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.99109634230399E-11 |
| Normal-vs-ccB subtype |
1.77791115163473E-12 |
| ccA subtype-vs-ccB subtype |
3.436600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63002944475465E-12 |
| Normal-vs-N1 |
5.50609999999674E-05 |
| N0-vs-N1 |
5.115000E-01 |
|
|
